7 Humanoid Robot Startups Racing to Replace Human Labor
Robots are working in Renault factories and SF Express warehouses today. Meet the 7 humanoid startups most likely to win the race to replace human labor.
Key Takeaways
- The money is real: Robotics startups raised $55.8 billion in 2026 alone, nearly double the prior-year record, according to Dealroom.
- Deployments over demos: RobotEra's humanoids already operate in 10-plus live logistics centers at 85% of human work efficiency, with thousand-unit deliveries in Q2 2026.
- Volume leader is already lapping the field: AgiBot shipped its 10,000th humanoid robot in March 2026 and holds an estimated 39% of global humanoid supply, according to Omdia.
- Europe's biggest bet is in Germany: NEURA Robotics closed a $1.4 billion Series C in June 2026 at a $7 billion valuation, backed by Amazon, Nvidia, and Qualcomm.
- The price floor is collapsing: Clone Robotics is targeting sub-$20,000 per humanoid unit, the threshold that would open the market from megafactories to every hotel and restaurant.
Manufacturers across Germany, Japan, and the United States are staring at record vacancy rates and declining applicant pools. Warehouse turnover regularly exceeds 100% per year. The short version: robots are no longer a luxury.
These aren't the companies you already know. Figure, Apptronik, Agility Robotics, and 1X Technologies already got their moment in our Physical AI roundup. The seven companies here are the next wave: funded, independently operating, and moving fast toward real commercial deployment of humanoid robots that do the jobs people no longer want to do.
Why Is This Happening Now?
Humanoid robots fit into factories designed for humans. They use the same tools, workstations, and safety protocols already in place. They don't require a factory redesign. They just need to be cheaper than the alternatives and reliable enough to work a full shift.
Both conditions are converging. Unit costs are falling. AI training pipelines are maturing. And the biggest industrial companies in the world, Renault, SF Express, Amazon, Bosch, are writing equity checks into humanoid startups. That is not a financial bet. That is a production plan.
Here are the seven companies building that future.
RobotEraSTAR1 humanoids deployed in live logistics centers
RobotEra builds general-purpose humanoid robots for logistics and industrial automation, with its STAR1 already deployed in real facilities handling package sorting and warehousing operations.
The company was founded in 2023 by Chen Jianyu, an assistant professor and doctoral supervisor at the Institute for Interdisciplinary Information at Tsinghua University, who earned his PhD in mechanical engineering at UC Berkeley under Professor Masayoshi Tomizuka, a member of the U.S. National Academy of Engineering. Tsinghua University holds an equity stake in the company.
RobotEra has raised more than $677 million across five rounds. In April 2026, the company closed a round of more than $200 million led by SF Group, the logistics conglomerate that is also its primary deployment customer, with participation from Hillhouse Investment, IDG Capital, and CICC Capital. A $143 million strategic financing in March 2026 included Samsung and Porsche.
Why it's spicy: RobotEra isn't running its robots in controlled environments. STAR1 units operate in more than 10 active logistics centers run by SF Express and China Post, achieving 85% of human work efficiency per company reporting. Thousand-unit deliveries began in Q2 2026. When your biggest customer is also your biggest investor, the revenue story becomes impossible to argue with.
AgiBotThe world's highest-volume humanoid robot maker
AgiBot (also known as Zhiyuan Robotics) builds general-purpose humanoid robots for logistics, retail, hospitality, and industrial manufacturing. The Shanghai-based company claims roughly 39% of global humanoid robot supply, according to Omdia research, and produced its 15,000th robot in late June 2026.
AgiBot was founded in February 2023 by Peng Zhihui and Deng Taihua. The company shipped more than 5,100 robots in 2025 and hit its 10,000th cumulative unit in March 2026. A lineup of four new robots debuted at the 2026 World Artificial Intelligence Conference in Shanghai.
The company has raised more than $725 million from Sequoia China, Hillhouse Capital, Tencent, BYD, and Alibaba, reaching a valuation of roughly $6.4 billion. AgiBot has announced plans for a Hong Kong IPO targeting HK$40 to HK$50 billion, with CICC, CITIC Securities, and Morgan Stanley as joint sponsors. As of July 2026, the company remains private.
Why it's spicy: Holding 39% market share in shipped humanoid units while your competitors are still running demo videos is not participating in a race. It is lapping the field. The IPO pursuit is the signal that AgiBot's investors believe the labor replacement market is large and stable enough to take public.
NEURA RoboticsCognitive humanoid robots for the factory floor
NEURA Robotics builds cognitive humanoid robots, including its 4NE-1 line designed for industrial work: welding, machine tending, gluing, and working alongside people in factories and logistics networks. The company is targeting 6,000 units shipped in 2026 and 10,000 in 2027.
NEURA was founded in 2019 by David Reger, a German-based entrepreneur who previously built three robotics and automation companies in Switzerland and coined the term "cognitive robotics." Reger moved back to Germany from Switzerland to establish the company in Metzingen, near Stuttgart.
In June 2026, NEURA announced a Series C of up to $1.4 billion, the largest funding round ever for a full-stack robotics company according to NEURA's own press release. Investors include Tether Holdings, Amazon, Nvidia, Qualcomm Ventures, Bosch, Schaeffler, and the European Investment Bank. The round pushed NEURA's valuation to approximately $7 billion.
Why it's spicy: Getting Amazon, Nvidia, Bosch, and Schaeffler on the same cap table is not an accident. These are the buyers and enablers of factory automation at global scale. When the chipmaker, the cloud giant, and two of the world's largest industrial manufacturers all write checks into the same humanoid startup, they are buying production capacity, not making a financial bet.
WandercraftCalvin humanoid robots built for real factory shifts
Wandercraft builds Calvin, an industrial humanoid robot already working on the factory floor of Renault's electric vehicle plant in Douai, France. The company began as a rehabilitation exoskeleton maker and pivoted into factory humanoids with striking speed: its first industrial humanoid was built in 40 days, repurposing exoskeleton components.
Wandercraft was founded in 2012 by Nicolas Simon, Matthieu Masselin, and Jean-Louis Constanza, whose family members' experiences with Charcot-Marie-Tooth disease motivated them to build machines that restore and extend human movement. The industrial humanoid is a direct extension of that capability applied to the factory.
Wandercraft raised a $75 million Series D in June 2025, led by Renault Group and Bpifrance as part of France's France 2030 strategic program, bringing total funding to approximately $137 million. In March 2026, Renault announced it will deploy 350 Calvin humanoids across its French and Spanish factories within 18 months.
Why it's spicy: Renault's commitment to 350 Calvin units is not a pilot program. It is a production order from one of Europe's largest automotive manufacturers, and it is already in motion. In a field full of demo videos, Wandercraft has something rarer: a customer who put a purchase order on the table.
FourierGR humanoid robots from healthcare to the assembly line
Fourier builds humanoid robots across rehabilitation, research, and industrial automation. Its GR series (GR-1, GR-2, GR-3) serves more than 2,000 medical institutions across 40-plus countries. The company began as a rehabilitation exoskeleton maker and has expanded its humanoid capabilities systematically toward factory environments.
Fourier was founded in 2015 in Shanghai by Alex Gu and Zen Koh. Its GR-2 model, launched in September 2024, stands 175 centimeters, weighs 63 kilograms, and features 53 degrees of freedom with a 12-DOF dexterous hand equipped with tactile sensors. The GR-3 variant, launched in August 2025 and debuted at CES 2026, targets emotional AI and eldercare environments.
Fourier has raised approximately $246 million in disclosed funding and reached a valuation of roughly $1.1 billion. The latest known round was a Series E+ of approximately $43 million in August 2025, led by Runyang Technology.
Why it's spicy: The company that spent a decade rehabbing patients is building the hands that will run factory floors. Fourier's 2,000-institution installed base in healthcare is not just a revenue line. It is one of the world's largest real-world training datasets for humanoid dexterity, gathered through years of robots moving alongside human patients.
This is the moment when systematic evaluation matters most. When a sector moves this fast, separating companies with real traction from great pitch decks is the entire game. Unicorn Screener is a research-backed scoring tool that evaluates founder quality, market dynamics, traction signals, and competitive position in a single structured assessment. You can see how any humanoid startup stacks up on our public /leaderboard before the next round reprices it.
Sanctuary AIPhoenix humanoid for real factory tasks
Sanctuary AI builds Phoenix, a general-purpose humanoid robot deployed in real manufacturing plants and retail environments, and claims demonstrated capability across more than 500 distinct real-world tasks.
Sanctuary was co-founded by Geordie Rose, who stepped down as CEO in November 2024. His replacement is Daniel Friedmann, the former longtime chief executive of MDA Space, the company responsible for building the Canadarm2 on the International Space Station. Friedmann is a manufacturing-scale operator taking the helm of a company that needed one.
Sanctuary has raised approximately $140 million in total, including a convertible note offering in early 2025 and a strategic investment from Japanese chemical firm Zeon. The company is actively pursuing additional capital.
Why it's spicy: Sanctuary is the most honest story in humanoid robotics: real factory deployments, a proven new CEO, and a tighter runway than its rivals. The question isn't whether the technology works. It is whether the balance sheet survives long enough for customers to scale their orders. For the investors who believe it does, this is the highest-risk, highest-differentiation bet on this list.
Clone RoboticsSynthetic humans powered by artificial muscles
Clone Robotics is building what it calls a synthetic human: a full-body robot powered by pneumatic artificial muscles designed to replicate the range of motion and dexterity of the human body, with a target price below $20,000. Its Clone Alpha androids entered limited release in 2025.
The company was co-founded by Dhanush Radhakrishnan and Lucas Kozlik, who began developing fluid artificial muscles in Poland in 2014. Clone has since expanded to dual bases in Poland and Mountain View, California.
Clone raised a $50 million round in 2026, led by Access VC and Initialized Capital, bringing total funding to roughly $67 million. A commercial robot targeting hospitality and service environments is planned for 2028.
Why it's spicy: The humanoid market's structural problem is price. At $200,000-plus per unit, humanoid robots are a niche industrial tool accessible only to the largest manufacturers. At $20,000, every hotel, restaurant, and small logistics operator becomes a potential buyer. Clone isn't building a better robot for the factory. It is trying to reshape who can afford a robot at all.
How to Think About This as an Investor
The seven companies above are evidence that the question has shifted. It is no longer "will robots replace human workers" but "which company wins which sector, and how fast."
Three signals separate real contenders from well-funded experiments:
Production contracts beat deployment announcements. RobotEra has active logistics center contracts. Renault put a 350-unit order on Wandercraft's books. AgiBot counts 15,000 cumulative units. These are measurable, verifiable numbers. Deployment announcements without unit counts and customer names are press releases, not traction.
Customer-as-investor is the highest validation. SF Group, Renault, Amazon, Bosch, and Schaeffler all took equity positions in their humanoid suppliers. When the companies deploying the robots also fund them, they are saying the product is worth owning, not just worth piloting.
Price determines the total addressable market. At current price points, humanoids serve large-scale industrial buyers. The companies that crack the $20,000 price point, whether Clone Robotics or someone else, will open a market ten times larger. Track who hits that threshold and when.
The how to evaluate AI startups before writing the check framework applies here too: no press coverage replaces the diligence question of whether a company has production contracts, paying customers, and a unit cost trajectory that closes on profitability.
One caveat worth stating plainly: no evaluation model predicts outcomes in a market this young. Hardware fails. Timelines slip. Safety incidents happen. Track the signals, not just the valuations.
Want to screen startups like a top-tier VC? Score any startup for free with our research-backed evaluation model.
Get the monthly edition
The three highest-scoring startups we screened this month, plus what is worth reading. One email, no noise.
Send me the monthly Unicorn Screener email. Unsubscribe anytime.